immune checkpoint inhibitors and their role in mm: pembrolizumab and durvalumab
Published 7 years ago • 133 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:53
toxicities and new immune checkpoint inhibitors
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
5:33
cancer immune checkpoint inhibitors
-
4:27
the role of immune checkpoint inhibitors in mds
-
1:51
checkpoint inhibition in the treatment of mpns
-
2:05
checkpoint inhibitors: parallel management of the disease and immune-related toxicities
-
12:12
immune checkpoint proteins
-
1:02:49
pd-l1/pd-1 cancer immunotherapy and new targets - gordon freeman, phd
-
36:14
tumor immunology
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
9:55
immune checkpoint inhibitors in acute leukemia
-
7:32
current immune checkpoint inhibitor trials in aml/mds
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
5:42
immune checkpoint inhibitors in mds and aml
-
2:15
cardiac biomarkers for immune checkpoint inhibitor-related myocarditis in cancer patients
-
3:21
nox2: a potential immune checkpoint for inhibition in aml
-
0:58
what are immune checkpoints?
-
1:10
the sensitization of immune checkpoint inhibitors with subsequent chemotherapy in r/r hl
-
2:28
checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to allosct for hl
-
1:29
blinatumomab in combination with checkpoint inhibitors for all
-
4:59
checkpoint inhibitors in aml
-
2:53
immune checkpoint inhibitors in mds: the i4mds consortium